Key result
Short tandem repeat expansions are increasingly recognized as the cause of skeletal muscle disorders, though clinical testing is complicated by reduced penetrance and evolving phenotypic spectrums.
Why the study?
To summarize current knowledge regarding the genetics and proposed disease mechanisms underlying skeletal muscle short tandem repeat expansion disorders.
This review highlights the growing recognition of skeletal muscle STR expansion disorders driven by advanced genomics, while noting ongoing challenges in clinical testing and understanding of pathomechanisms.
Answers are grounded in this paper and cite their sources.
Advances STR genetics in skeletal muscle; leaves open cardiac phenotype links and therapeutic translation.
PURPOSE OF REVIEW: Here, we summarize the current knowledge about the genetics and proposed mechanisms of disease underlying skeletal muscle short tandem repeat (STR) expansion disorders. RECENT FINDINGS: The human genome contains up to 2 million STRs (also known as microsatellites), which are highly variable repetitions of two to six nucleotide-long DNA motifs. These elements, present in both coding and noncoding sequences, are highly instable, and their polymorphic variations have important roles in genes regulation and human phenotypic trait diversity. Importantly, expansion over a threshold size of a subset of these STR is the cause of approximately 60 neurological diseases, including some major muscle disorders such as myotonic dystrophy, oculopharyngodistal myopathy (OPDM) and oculopharyngeal muscular dystrophy. The discovery and characterisation of a number of these STR expansion disorders, in particular for OPDM, has been enabled in recent years by advanced genomic technologies. SUMMARY: Many recently described STR expansion disorders are now recognized and genetic testing of patients is possible on a research basis, clinical testing for these newly described repeat loci is not yet readily available and is complicated by the reduced penetrance seen in some families, rendering clinical interpretation more difficult. The phenotypic spectrums associated with these STR expansion disorders are also evolving as unbiased sequencing approaches identified expansions at known loci in individuals with phenotypes that are quite different to those in which the STR expansions were first characterized. The pathomechanisms associated with these newer STR expansion disorders is still poorly understood, however there is evidence of both RNA toxicity and polyGly toxicity. Additional STR expansions underlying skeletal muscle diseases are likely to be identified in coming years and may shed further light onto the complex genetics, epigenetics and disease mechanisms underlying these disorders.
No takes yet. Share an insight, caveat, or question.
Boivin et al. (2025) conducted a review in Skeletal muscle short tandem repeat (STR) expansion disorders. Short tandem repeat (STR) expansions was evaluated. Short tandem repeat expansions are increasingly recognized as the cause of skeletal muscle disorders, though clinical testing is complicated by reduced penetrance and evolving phenotypic spectrums.
Synapse has enriched 10 related papers. Consider them for comparative context: